Julie L Engers

9PUBLICATIONS
15CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesBiomolecular modelling and designBiologically active moleculesPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 14, 2026
Discovery of VU6083859, a TAOK1 Selective Inhibitor, and VU6080195, a pan-TAOK Activator.

Daniel C Schultz, Lauren C Parr, Hunter Sweet

|Nov 26, 2025
Discovery of VU6052254: A Novel, Potent M1 Positive Allosteric Modulator.

Julie L Engers, Joseph D Bungard, Christopher C Presley

|Jul 16, 2025
Discovery of a Novel sp3‑Rich M1 Positive Allosteric Modulators (PAMs) Chemotype via Scaffold Hopping.

Joseph D Bungard, Paul Spearing, Yu Nishio

|May 14, 2025
Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5.

Katherine E Crocker, Scott H Henderson, Rory A Capstick

|Apr 01, 2025
Total Synthesis and Pharmacological Evaluation of Phochrodines A-C.

Jacob L Bouchard, Sichen Chang, Srinivasan Krishnan

|Mar 25, 2025
Application of Deuterium in an M1 Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422.

Julie L Engers, Jinming Li, Changho Han

Pageof 2